PRE | Prenetics Global Limited Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	4.41 - 4.82
52 Week Range	2.8500 - 7.84
Beta	0.83
Implied Volatility	3.91%
IV Rank	N/A
Day's Volume	14,639
Average Volume	15,088
Shares Outstanding	12,217,226
Market Cap	57,665,307
Sector	Healthcare
Industry	Medical - Diagnostics & Research
IPO Date	2021-07-16

Valuation
Profitability
Growth
Health
P/E Ratio	-1.36
Forward P/E Ratio	N/A
EPS	-3.47
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	320
Country	Hong Kong
Website	PRE

Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

PRE's peers: ACRS, APDN, BDSX, CHEK, MYNZ, TRIB, NEOG, QGEN, OLK, SYNH, FONR, BNR, SERA, LMDX, GTH, CSTL, MDXH, NOTV, DRIO, XGN

*Chart delayed

Analyzing fundamentals for PRE we got that it has weak fundamentals where Valuation is considered to be overvalued, Profitability is unacceptably poor, Growth is very bad and Health is weak. For more detailed analysis please see PRE Fundamentals page.

Watching at PRE technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, but short-term trend is bullish. More technicals details can be found on PRE Technicals page.